Blackthorn Therapeutics' Spinoff / Spinout Round

Blackthorn Therapeutics raised a round of funding on January 01, 2013. Investors include Scripps Research Institute.

Blackthorn Therapeutics is developing targeted medicines for neurodevelopmental disorders. BlackThorn leverages its INFORM platform, which supports the discovery and development of targeted treatments…

Articles about Blackthorn Therapeutics' Spinoff / Spinout Round: